Health ❯ Healthcare ❯ Biotechnology

Drug Development

Clinical Trials FDA Approval Startup Support Cell Therapy Neuromuscular Disorders Gene Therapy Oncology Clinical Research Cancer Research Obesity Treatment Molecular Glue Degraders Petosemtamab mRNA Vaccines Mental Health Treatments Corcept Therapeutics Incorporated Gilead Sciences Allergy Treatments

8 ARTICLES

last mo.

MoonLake Investors Face Dec. 15 Lead-Plaintiff Deadline in SDNY Securities Case

Investors have until December 15, 2025 to seek lead-plaintiff status in the SDNY case alleging misstatements about sonelokimab's touted Nanobody advantages.

6 ARTICLES

2mo ago

MoonLake Faces Securities Class Action After SLK Trial Miss as Firms Seek Lead Plaintiff

11 ARTICLES

2mo ago

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug